Two years later, that number soared to 11 percent, with 15 percent (almost 1 in 6 people) reporting having used one at some point
Lana Rodriguez, 37, started taking semaglutide as a weekly injection in September 2022 after years of binge eating and weight cycling
This is the reality for millions living with Long COVID symptoms, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), and complex chronic conditions like dysautonomia and mast cell activation syndrome (MCAS)
Side effects can be different depending on factors such as age and medical history
Addresses both sides of the energy equation simultaneously
The primary endpoint is the proportion of participants achieving a clinically meaningful response, defined by weight loss and/or reduction in hyperphagia